Concerning the soluble activators of FZD, previous studies have shown the common downregulation of sFRP1 due to promoter hypermethylation in HCC as well as in colon cancer (Suzuki et al, 2004; Shih et al, 2006, 2007). The gene discussed is SFRP1; the disease is hepatocellular carcinoma.